Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials

Heart failure with preserved ejection fraction (HFpEF) is a disease with limited evidence-based treatment options. Mineralocorticoid receptor antagonists (MRA) offer benefit in heart failure with reduced ejection fraction (HFrEF), but their impact in HFpEF remains unclear. We therefore evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapelios, Chris J., Murrow, Jonathan R., Nührenberg, Thomas G., Montoro Lopez, Maria N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477010/
https://www.ncbi.nlm.nih.gov/pubmed/30618017
http://dx.doi.org/10.1007/s10741-018-9758-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477010/
https://www.ncbi.nlm.nih.gov/pubmed/30618017
http://dx.doi.org/10.1007/s10741-018-9758-0

Ejemplares similares